HBV reactivation after start of bulevirtide mono-treatment for a HBV/HDV coinfected patient: a case report
Zeitschrift Fur Gastroenterologie(2023)
Abstract
Background Bulevirtide is the first in-label treatment option for HBV/HDV coinfection in combination with nucleos(t)ide (NA) analogues or as monotherapy. We report a case of a patient with hepatitis B reactivation after start of bulevirtide monotreatment, which resulted in the need for a NA-start.
MoreTranslated text
Key words
hbv/hdv,mono-treatment
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined